Christoffer Gebhardt: Can Anticoagulation Improve Outcomes in Melanoma Therapy?
Christoffer Gebhardt, Professor, Head of Skin Cancer Center and Vice Head of Department of Dermatology at The University Hospital Hamburg-Eppendorf, shared on LinkedIn:
”Antithrombotic therapies – particularly factor Xa inhibitors and anti-platelet agents – may limit melanoma metastasis and improve outcomes alongside established systemic treatments.
In patients receiving immune checkpoint inhibition (ICI), concomitant anticoagulation (AC) was associated with improved survival, while with targeted therapy (TT) concurrent AC enhanced both progression-free (PFS) and overall survival (OS).
Additionally, platelet inhibition with TT was linked to better OS after the first year.
These findings support the rationale for prospective clinical trials evaluating anticoagulation as a concomitant strategy in melanoma therapy.
Kudos to the first authors Julian Kött and Nina Matthes and all co-authors pushing translational research forward at the intersection of thrombosis and melanoma therapy!”
Title: Synergistic effects of anticoagulants and platelet aggregation inhibitors with immune checkpoint inhibitors in cancer therapy: a comprehensive review of preclinical and clinical evidence
Authors: Julian Kött, Nina Matthes, Alexander T Bauer, Noah Zimmermann, Tim Zell, Daniel J Smit, Stefan W Schneider, Christoffer Gebhardt
Read the Full Article on Journal for ImmunoTherapy of Cancer
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026
-
Jul 12, 2026, 06:59Maaike Sybil Jongen: Flow Cytometry for Platelet Phenotyping at ISTH 2026